A systematic review of evidence-based community pharmacy services aimed at the prevention of cardiovascular disease

Sabater-Hernández, D; Sabater-Galindo, M; Fernandez-Llimos, F; Rotta, I; Hossain, LN; Durks, D; Franco-Trigo, L; Lopes, LA; Correr, CJ; Benrimoj, SI

A systematic review of evidence-based community pharmacy services aimed at the prevention of cardiovascular disease

Sabater-Hernández, D

Sabater-Galindo, M Fernandez-Llimos, F

Rotta, I Hossain, LN

Durks, D Franco-Trigo, L

Lopes, LA Correr, CJ Benrimoj, SI

Permalink

Publication Type:: Journal Article
Citation:: Journal of Managed Care and Specialty Pharmacy, 2016, 22 (6), pp. 699 - 713
Issue Date:: 2016-06-01

Closed Access

	Filename	Description	Size
	2016_SR_CPharmIntervent.pdf	Published Version	283.53 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Sabater-Hernández, D https://orcid.org/0000-0001-7419-8740	en_US
dc.contributor.author	Sabater-Galindo, M	en_US
dc.contributor.author	Fernandez-Llimos, F https://orcid.org/0000-0002-8529-9595	en_US
dc.contributor.author	Rotta, I	en_US
dc.contributor.author	Hossain, LN https://orcid.org/0000-0001-5432-5853	en_US
dc.contributor.author	Durks, D	en_US
dc.contributor.author	Franco-Trigo, L https://orcid.org/0000-0001-6833-6035	en_US
dc.contributor.author	Lopes, LA	en_US
dc.contributor.author	Correr, CJ	en_US
dc.contributor.author	Benrimoj, SI https://orcid.org/0000-0001-9768-7838	en_US
dc.date.issued	2016-06-01	en_US
dc.identifier.citation	Journal of Managed Care and Specialty Pharmacy, 2016, 22 (6), pp. 699 - 713	en_US
dc.identifier.issn	2376-0540	en_US
dc.identifier.uri	http://hdl.handle.net/10453/122760
dc.description.abstract	© 2016, Academy of Managed Care Pharmacy. BACKGROUND: Cardiovascular disease (CVD) is the leading cause of death worldwide and has a substantial impact on people's health and quality of life. CVD also causes an increased use of health care resources and services, representing a significant proportion of health care expenditure. Integrating evidence-based community pharmacy services is seen as an asset to reduce the burden of CVD on individuals and the health care system. OBJECTIVES: To (a) identify community pharmacy evidence-based services designed to help prevent CVD and (b) provide fundamental information that is needed to assess their potential adaptation to other community pharmacy settings. METHODS: This review used the DEPICT database, which includes 488 randomized controlled trials (RCT) that address the evaluation of pharmacy services. Articles reviewing these RCTs were identified for the DEPICT database through a systematic search of the following databases: MEDLINE, Scopus, SciELO (Scientific Electronic Library Online), and DOAJ (Directory of Open Access Journals). The DEPICT database was reviewed to identify evidence-based services delivered in the community pharmacy setting with the purpose of preventing CVD. An evidence-based service was defined as a service that has been shown to have a positive effect (compared with usual care) in a high-quality RCT. From each evidence-based service, fundamental information was retrieved to facilitate adaptation to other community pharmacy settings. RESULTS: From the DEPICT database, 14 evidence-based community pharmacy services that addressed the prevention of CVD were identified. All services, except 1, targeted populations with a mean age above 60 years. Pharmacy services encompassed a wide range of practical applications or techniques that can be classified into 3 groups: activities directed at patients, activities directed at health care professionals, and assessments to gather patient-related information in order to support the previous activities. CONCLUSIONS: This review provides pharmacy service planners and policymakers with a comprehensive list of evidence-based services that have the potential to be adapted to different settings from which they were originally implemented and evaluated in order to reduce the burden of CVD.	en_US
dc.relation.ispartof	Journal of Managed Care and Specialty Pharmacy	en_US
dc.relation.isbasedon	10.18553/jmcp.2016.22.6.699	en_US
dc.subject.mesh	Humans	en_US
dc.subject.mesh	Cardiovascular Diseases	en_US
dc.subject.mesh	Professional Role	en_US
dc.subject.mesh	Databases, Factual	en_US
dc.subject.mesh	Pharmacists	en_US
dc.subject.mesh	Community Pharmacy Services	en_US
dc.subject.mesh	Randomized Controlled Trials as Topic	en_US
dc.subject.mesh	Evidence-Based Practice	en_US
dc.title	A systematic review of evidence-based community pharmacy services aimed at the prevention of cardiovascular disease	en_US
dc.type	Journal Article
utslib.citation.volume	6	en_US
utslib.citation.volume	22	en_US
utslib.for	1115 Pharmacology and Pharmaceutical Sciences	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Business
pubs.organisational-group	/University of Technology Sydney/Graduate School of Health
pubs.organisational-group	/University of Technology Sydney/Students
utslib.copyright.status	closed_access
pubs.issue	6	en_US
pubs.publication-status	Published	en_US
pubs.volume	22	en_US

Abstract:

© 2016, Academy of Managed Care Pharmacy. BACKGROUND: Cardiovascular disease (CVD) is the leading cause of death worldwide and has a substantial impact on people's health and quality of life. CVD also causes an increased use of health care resources and services, representing a significant proportion of health care expenditure. Integrating evidence-based community pharmacy services is seen as an asset to reduce the burden of CVD on individuals and the health care system. OBJECTIVES: To (a) identify community pharmacy evidence-based services designed to help prevent CVD and (b) provide fundamental information that is needed to assess their potential adaptation to other community pharmacy settings. METHODS: This review used the DEPICT database, which includes 488 randomized controlled trials (RCT) that address the evaluation of pharmacy services. Articles reviewing these RCTs were identified for the DEPICT database through a systematic search of the following databases: MEDLINE, Scopus, SciELO (Scientific Electronic Library Online), and DOAJ (Directory of Open Access Journals). The DEPICT database was reviewed to identify evidence-based services delivered in the community pharmacy setting with the purpose of preventing CVD. An evidence-based service was defined as a service that has been shown to have a positive effect (compared with usual care) in a high-quality RCT. From each evidence-based service, fundamental information was retrieved to facilitate adaptation to other community pharmacy settings. RESULTS: From the DEPICT database, 14 evidence-based community pharmacy services that addressed the prevention of CVD were identified. All services, except 1, targeted populations with a mean age above 60 years. Pharmacy services encompassed a wide range of practical applications or techniques that can be classified into 3 groups: activities directed at patients, activities directed at health care professionals, and assessments to gather patient-related information in order to support the previous activities. CONCLUSIONS: This review provides pharmacy service planners and policymakers with a comprehensive list of evidence-based services that have the potential to be adapted to different settings from which they were originally implemented and evaluated in order to reduce the burden of CVD.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/122760